UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Endometrial regenerative cells: a novel stem cell population

Journal of translational medicine, 2007-11, Vol.5 (1), p.57-57, Article 57

2007

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells

Cancer research (Chicago, Ill.), 2007-01, Vol.67 (2), p.746-755

2007

Link zum Volltext

Verfügbarkeit prüfen

The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance

Journal of molecular medicine (Berlin, Germany), 2020-08, Vol.98 (8), p.1161-1173

2020

Link zum Volltext

Verfügbarkeit prüfen

A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure

American journal of physiology. Heart and circulatory physiology, 2018-09, Vol.315 (3), p.H563-H570

2018

Link zum Volltext

Verfügbarkeit prüfen

Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Journal of translational medicine, 2009-12, Vol.7 (1), p.106-106, Article 106

2009

Link zum Volltext

Verfügbarkeit prüfen

Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects

Journal of translational medicine, 2010-04, Vol.8 (1), p.34-34, Article 34

2010

Link zum Volltext

Verfügbarkeit prüfen

Substituent Effects on the C−H Bond Dissociation Energy of Toluene. A Density Functional Study

Journal of organic chemistry, 1996-01, Vol.61 (2), p.746-750

1996

Link zum Volltext

Verfügbarkeit prüfen

Porphyrin Isomers: Geometry, Tautomerism, Geometrical Isomerism, and Stability

Journal of organic chemistry, 1997-12, Vol.62 (26), p.9240-9250

1997

Link zum Volltext

Verfügbarkeit prüfen

Theoretical Study of Peptides Formed by Aminoxy Acids

Journal of the American Chemical Society, 1999-12, Vol.121 (48), p.11189-11196

1999

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-211: Synergistic anti-metastatic effect of pembrolizumab in combination with a novel mTORC1 inhibitor/AMPK agonist in a CAM metastatic triple negative breast cancer model

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.LB-211-LB-211

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 15417: Dual Ampk Activator/mtor Inhibitor Improves Metabolic Parameters in T2d Mice and Protects Cardiomyocytes Against Ischemic Injury

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Link zum Volltext

Verfügbarkeit prüfen

An Unusual Turn Structure in Peptides Containing α-Aminoxy Acids

Journal of the American Chemical Society, 1996-10, Vol.118 (40), p.9794-9795

1996

Link zum Volltext

Verfügbarkeit prüfen

From Porphyrin Isomers to Octapyrrolic "Figure Eight" Macrocycles

Angewandte Chemie (International ed.), 1995-12, Vol.34 (22), p.2511-2514

1995

Link zum Volltext

Verfügbarkeit prüfen

Abstract 17055: Novel Dual mTOR Inhibitor/AMPK Activator Mitigates Doxorubicin Cardiotoxicity and Potentiates Its Chemotherapeutic Efficacy Against Triple Negative Breast Cancer

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A17055-A17055

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1963: Targeting hematological malignancies with two functionally and mechanistically distinct classes of cereblon mediated protein homeostatic modulators

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1963-1963

2020

Link zum Volltext

Verfügbarkeit prüfen

Computational and Experimental Studies on the Thermolysis Mechanism of Zirconium and Hafnium Tetraalkyl Complexes. Difference between Titanium and Zirconium Complexes

Organometallics, 1999-05, Vol.18 (11), p.2081-2090

1999

Link zum Volltext

Verfügbarkeit prüfen

Trial in Progress: A Phase I Trial of BTX-A51 in Patients with Relapsed or Refractory AML or High-Risk MDS

Blood, 2020-11, Vol.136 (Supplement 1), p.18-19

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 14309: A Novel Fibroblast Activation Inhibitor, NM922, Attenuates Maladaptive Fibrotic Remodeling to Preserve Cardiac Function Following the Onset of Heart Failure

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A14309-A14309

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4527: Oral multi-pathway inhibitors for the treatment of triple negative breast cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4527-4527

2014

Link zum Volltext

Verfügbarkeit prüfen

Transition Structures of Methane Elimination in Pentamethylniobium and Pentamethyltantalum

Journal of the American Chemical Society, 1995-09, Vol.117 (36), p.9259-9264

1995

Link zum Volltext

Verfügbarkeit prüfen

Targeting AML: The Development of Two Functionally and Mechanistically Distinct Classes of Cereblon-Mediated Protein Homeostatic Modulators

Blood, 2019-11, Vol.134 (Supplement_1), p.3361-3361

2019

Link zum Volltext

Verfügbarkeit prüfen

Bioavailable Dual-Protein Degraders of CK1α and Transcriptional Kinase CDK9 As Potential Therapeutics for Hematological Malignancies

Blood, 2019-11, Vol.134 (Supplement_1), p.4643-4643

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3830: Novel small molecule translation inhibitors with safety and efficacy in triple negative breast cancer (TNBC) animal models

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3830-3830

2012

Link zum Volltext

Verfügbarkeit prüfen

Protein Homeostatic Modulators, a Novel Class of Cereblon-Targeting Small Molecules As Potential Clinical Candidates in Multiple Myeloma

Blood, 2017, Vol.130, p.4418-4418

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Endometrial regenerative cells: a novel stem cell population

Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells

The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance

A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure

Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors

Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects

Substituent Effects on the C−H Bond Dissociation Energy of Toluene. A Density Functional Study

Porphyrin Isomers: Geometry, Tautomerism, Geometrical Isomerism, and Stability

Theoretical Study of Peptides Formed by Aminoxy Acids

Abstract LB-211: Synergistic anti-metastatic effect of pembrolizumab in combination with a novel mTORC1 inhibitor/AMPK agonist in a CAM metastatic triple negative breast cancer model

Abstract 15417: Dual Ampk Activator/mtor Inhibitor Improves Metabolic Parameters in T2d Mice and Protects Cardiomyocytes Against Ischemic Injury

An Unusual Turn Structure in Peptides Containing α-Aminoxy Acids

From Porphyrin Isomers to Octapyrrolic "Figure Eight" Macrocycles

Abstract 17055: Novel Dual mTOR Inhibitor/AMPK Activator Mitigates Doxorubicin Cardiotoxicity and Potentiates Its Chemotherapeutic Efficacy Against Triple Negative Breast Cancer

Abstract 1963: Targeting hematological malignancies with two functionally and mechanistically distinct classes of cereblon mediated protein homeostatic modulators

Computational and Experimental Studies on the Thermolysis Mechanism of Zirconium and Hafnium Tetraalkyl Complexes. Difference between Titanium and Zirconium Complexes

Trial in Progress: A Phase I Trial of BTX-A51 in Patients with Relapsed or Refractory AML or High-Risk MDS

Abstract 14309: A Novel Fibroblast Activation Inhibitor, NM922, Attenuates Maladaptive Fibrotic Remodeling to Preserve Cardiac Function Following the Onset of Heart Failure

Abstract 4527: Oral multi-pathway inhibitors for the treatment of triple negative breast cancer

Transition Structures of Methane Elimination in Pentamethylniobium and Pentamethyltantalum

Targeting AML: The Development of Two Functionally and Mechanistically Distinct Classes of Cereblon-Mediated Protein Homeostatic Modulators

Bioavailable Dual-Protein Degraders of CK1α and Transcriptional Kinase CDK9 As Potential Therapeutics for Hematological Malignancies

Abstract 3830: Novel small molecule translation inhibitors with safety and efficacy in triple negative breast cancer (TNBC) animal models

Protein Homeostatic Modulators, a Novel Class of Cereblon-Targeting Small Molecules As Potential Clinical Candidates in Multiple Myeloma

Suchergebnisse filtern